• 1. A naked-eye visible and fluorescence “turn-on” probe for acetyl-cholinesterase assay and thiols as well as imaging of living cells
  Kai Cui,Zhenling Chen,Zhuo Wang,Guanxin Zhang,Deqing Zhang Analyst 2011 136 191
• 2. Aqueous carbofuran removal using slow pyrolyzed sugarcane bagasse biochar: equilibrium and fixed-bed studies
  Vineet Vimal,Manvendra Patel,Dinesh Mohan RSC Adv. 2019 9 26338
• 3. Modelling carbofuran biotransformation by Novosphingobium sp. KN65.2 in the presence of coincidental carbon and indigenous microbes
  Li Liu,Damian E. Helbling,Hans-Peter E. Kohler,Barth F. Smets Environ. Sci.: Water Res. Technol. 2019 5 798
• 4. Boron-doped and serine and histidine-functionalized graphene quantum dots with strong yellow fluorescence emissions for highly sensitive detection of carbofuran in cucumber and cabbage
  Na Wang,Ruiyi Li,Qinsheng Wang,Yongqiang Yang,Nana Li,Zaijun Li New J. Chem. 2021 45 17258
• 5. Sensitive and selective detection of the highly toxic pesticide carbofuran in vegetable samples by a molecularly imprinted electrochemical sensor with signal enhancement by AuNPs
  Peipei Qi,Jiao Wang,Xiangyun Wang,Zhiwei Wang,Hao Xu,Shanshan Di,Qiang Wang,Xinquan Wang RSC Adv. 2018 8 25334

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Overview of Carbocisteine (CAS No. 2387-59-9): Mechanism, Applications, and Modern Research Insights

Carbocisteine (CAS No. 2387-59-9), also known as S-carboxymethylcysteine, is a mucolytic agent widely used in respiratory therapeutics. Its chemical structure, C5H9NO4S, features a carboxyl group that enhances its solubility and bioavailability. This compound is particularly effective in managing chronic obstructive pulmonary disease (COPD), bronchitis, and other conditions involving excessive mucus production. Recent studies highlight its role in modulating mucin secretion, making it a focal point for researchers exploring respiratory health innovations.

The mechanism of carbocisteine involves breaking disulfide bonds in mucus glycoproteins, reducing viscosity and facilitating expectoration. Unlike other mucolytics such as acetylcysteine, carbocisteine exhibits additional immunomodulatory effects, including suppression of pro-inflammatory cytokines like IL-6 and TNF-α. This dual action aligns with current trends in personalized medicine, where patients seek therapies addressing both symptoms and underlying inflammation. Clinicians often prescribe it as part of combination therapies for chronic respiratory conditions.

In the context of post-pandemic health awareness, carbocisteine has gained attention for its potential adjunctive role in long-term respiratory recovery. Searches for "mucolytic agents for lung health" and "best expectorants 2024" reflect growing public interest. Notably, its safety profile makes it suitable for pediatric and geriatric populations, addressing concerns about drug interactions and side effects—a frequent query in patient forums and healthcare SEO trends.

Pharmaceutical formulations of carbocisteine include syrups, capsules, and effervescent tablets, with bioavailability ranging from 60% to 80%. Recent pharmacokinetic studies emphasize its rapid absorption in the gastrointestinal tract, with peak plasma concentrations achieved within 2 hours. This data is critical for optimizing dosing regimens, especially in telemedicine consultations where patients inquire about "how to take carbocisteine effectively."

Emerging research explores carbocisteine's potential beyond respiratory care. Preliminary findings suggest it may modulate gut microbiota by influencing sulfur metabolism, a topic gaining traction in microbiome therapeutics. Such interdisciplinary applications position carbocisteine as a compound of interest in nutraceutical development and functional foods—key areas in 2024 pharmaceutical trends.

Quality control in carbocisteine production adheres to ICH Q7 guidelines, with HPLC being the standard analytical method. Manufacturers prioritize green chemistry approaches to reduce environmental impact, responding to searches for "sustainable pharmaceutical synthesis." Regulatory agencies like the EMA and FDA classify it as a non-prescription drug in many jurisdictions, though formulations vary by region—a nuance often queried in global health databases.

Consumer education remains vital, as evidenced by frequent searches for "carbocisteine vs guaifenesin" and "natural alternatives to mucolytics." Healthcare providers emphasize carbocisteine's evidence-based efficacy while acknowledging patient preferences for integrative therapies. This balanced perspective enhances patient adherence and aligns with value-based healthcare models dominating current medical SEO discussions.

• 25635-80-7(Cysteine,S-(2-carboxyethyl)-)
• 29433-95-2(L-Cysteine,S-(carboxymethyl)-, homopolymer)
• 1115-93-1(L-Cysteine, S-propyl-)
• 6367-98-2(S-(2-Hydroxyethyl)-L-cysteine)
• 85955-36-8(S-2-Hydroxyethyl-D-cysteine)
• 104640-54-2(L-Cysteine,S-(1-carboxyethyl)-)
• 2936-69-8(L-Cysteine,S-(2-aminoethyl)-)
• 141814-32-6(L-Cysteine,S-(2-oxoethyl)-)
• 186537-58-6(Carboxymethylcysteine)
• 638-23-3(Carbocisteine)